Age, Biography and Wiki
Amy Doneen (Amy Lynn Hubbard) was born on 1969 in United States, is an American doctor of nursing practice. Discover Amy Doneen's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 55 years old?
We recommend you to check the complete list of Famous People born on .
He is a member of famous Doctor with the age 55 years old group.
Amy Doneen Height, Weight & Measurements
At 55 years old, Amy Doneen height not available right now. We will update Amy Doneen's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Amy Doneen Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Amy Doneen worth at the age of 55 years old? Amy Doneen’s income source is mostly from being a successful Doctor. He is from United States. We have estimated Amy Doneen's net worth, money, salary, income, and assets.
Net Worth in 2024 |
$1 Million - $5 Million |
Salary in 2024 |
Under Review |
Net Worth in 2023 |
Pending |
Salary in 2023 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
Doctor |
Amy Doneen Social Network
Timeline
Amy Lynn Doneen (born in 1969) is an American doctor of nursing practice (DNP) and co-founder of the BaleDoneen Method for the prevention and treatment of heart attack, stroke and type 2 diabetes, and for treatment after one of these medical events.
She holds professorships at Washington State University School of Medicine, University of Kentucky College of Dentistry and Texas Tech University Health Science Center.
Doneen received her associate degree in nursing (ADN) and registered nurse (RN) degrees from Spokane Community College.
After graduating from nursing school, she worked for 10 years as a registered nurse.
She subsequently received her Bachelor of Nursing Science (BSN), Master of Science in Nursing (MSN) and Advanced Registered Nurse Practitioner (ARNP) degrees from Gonzaga University.
Born Amy Lynn Hubbard to American parents in Heidelberg, Germany, she married Daren Doneen in 1994.
The couple has three children.
In 2000, while at Gonzaga, Doneen met Bradley Field Bale, then a family physician in Spokane whose practice focused on early detection and treatment of cardiovascular disease.
Intrigued by one of the imaging technologies Bale was using to screen patients for arterial disease, called electron beam tomography (EBT), and wrote her dissertation on “The Relationship between Electron Beam Computed Tomography Calcium Scores and established Clinical and Serologic Risk Factors for Coronary Artery Disease,” was published in 2003.
In 2004, she and Bale cofounded the BaleDoneen Method.
Since 2005, Doneen has been the owner and medical director of the Heart Attack & Stroke Prevention Center in Spokane, Washington, a private clinical practice that treats patients using the BaleDoneen Method.
A 2012 scientific statement from the American Heart Association, however, states that while observational studies support an association between periodontal disease and heart disease, independent of known confounders, these studies "do not support a causal relationship."
Doneen, Bradley Bale and Lisa Collier Cool published the 2013 book, v
Postgraduate Medical Journal titled, “High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis.
In 2014, she became the first graduate of Gonzaga's Doctor of Nursing Practice (DNP) Program.
In 2015, Doneen and Bale launched a nonprofit organization, the Institute of Arteriology dedicated to advancing “arteriology,” the study of arteries, and conducting research.
One of its objectives, in collaboration with Johns Hopkins School of Medicine, “is the establishment of a longitudinal, interventional registry of patients who have been screened to assess their cardiovascular disease risk by evaluating their subclinical arterial disease state and then treated to optimize arterial health.”